COVID-19 Vaccine: First batch of Russian candidate Sputnik-V to reach Kanpur for Phase 2 & 3 trials

. College principal R B Kamal confirmed that the human clinical trials of the vaccine begin next week.

The first batch of Russia’s vaccine candidate for COVID-19, Sputnik-V is likely to arrive by next week at Ganesh Shankar Vidyarthi Medical College in Kanpur to conduct its Phase 2 and Phase 3 human clinical trials. The approval to conduct the human clinical trials of the vaccine was granted to it after Dr Reddy’s Laboratories got the approval from the Drugs Controller General of India (DCGI) in this regard, sources confirmed. College principal R B Kamal confirmed that the human clinical trials of the vaccine begin next week.

“As many as 180 volunteers have registered for the trials. Head of the research Saurabh Agarwal will determine the dosage of the vaccine to be administered. One dose will be administered and the condition of volunteers will be monitored to determine whether they need further doses or not,” he stated. Kamal emphasised that the vitals and condition of the volunteers will be checked periodically and that data will be analysed to decide whether the vaccine is effective or not.

Advertisement

According to Kamal, the effect of the vaccine on the volunteers will be observed for seven months after it is administered once, twice or thrice within an interval of 21 days. Post observation of the effects of the vaccine for a month’s duration, authorities will be gauged of the results of the trial and will then make a decision accordingly.